GSK Plc Return On Asset vs. Price To Earnings To Growth
| G1SK34 Stock | BRL 41.00 0.72 1.73% |
For GSK Plc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GSK Plc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GSK plc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GSK Plc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GSK plc over time as well as its relative position and ranking within its peers.
GSK |
GSK plc Price To Earnings To Growth vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining GSK Plc's current stock value. Our valuation model uses many indicators to compare GSK Plc value to that of its competitors to determine the firm's financial worth. GSK plc is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in price to earnings to growth category among its peers producing about 6.77 of Price To Earnings To Growth per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value GSK Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GSK Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GSK Price To Earnings To Growth vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
GSK Plc |
| = | 0.0659 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
GSK Plc |
| = | 0.45 X |
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
GSK Price To Earnings To Growth Comparison
GSK Plc is currently under evaluation in price to earnings to growth category among its peers.
GSK Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on GSK Plc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GSK Plc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GSK Plc's important profitability drivers and their relationship over time.
Use GSK Plc in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GSK Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GSK Plc will appreciate offsetting losses from the drop in the long position's value.GSK Plc Pair Trading
GSK plc Pair Trading Analysis
The ability to find closely correlated positions to GSK Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GSK Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GSK Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GSK plc to buy it.
The correlation of GSK Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GSK Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GSK plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GSK Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your GSK Plc position
In addition to having GSK Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in GSK Stock
To fully project GSK Plc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of GSK plc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include GSK Plc's income statement, its balance sheet, and the statement of cash flows.